Cargando…

A stochastically curtailed single-arm phase II trial design for binary outcomes

Phase II clinical trials are a critical aspect of the drug development process. With drug development costs ever increasing, novel designs that can improve the efficiency of phase II trials are extremely valuable. Phase II clinical trials for cancer treatments often measure a binary outcome. The fin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Law, Martin, Grayling, Michael J., Mander, Adrian P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614398/ https://www.ncbi.nlm.nih.gov/pubmed/35077268 http://dx.doi.org/10.1080/10543406.2021.2009498

Ejemplares similares

A stochastically curtailed two-arm randomised phase II trial design for binary outcomes
por: Law, Martin, et al.
Publicado: (2021)

Re-formulating Gehan’s design as a flexible two-stage single-arm trial
por: Grayling, Michael J., et al.
Publicado: (2019)

Two-Stage Single-Arm Trials Are Rarely Analyzed Effectively or Reported Adequately
por: Grayling, Michael J., et al.
Publicado: (2021)

Do single‐arm trials have a role in drug development plans incorporating randomised trials?
por: Grayling, Michael J., et al.
Publicado: (2015)

An optimised multi-arm multi-stage clinical trial design for unknown variance
por: Grayling, Michael J., et al.
Publicado: (2018)

Exact group sequential designs for two-arm experiments with Poisson distributed outcome variables
por: Grayling, Michael J., et al.
Publicado: (2021)

A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials
por: Grayling, Michael J, et al.
Publicado: (2019)

Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials
por: Mossop, Helen, et al.
Publicado: (2021)

Stepped wedge cluster randomized controlled trial designs: a review of reporting quality and design features
por: Grayling, Michael J., et al.
Publicado: (2017)

Group sequential designs for stepped-wedge cluster randomised trials
por: Grayling, Michael J, et al.
Publicado: (2017)

Admissible multiarm stepped‐wedge cluster randomized trial designs
por: Grayling, Michael J., et al.
Publicado: (2018)

Group sequential crossover trial designs with strong control of the familywise error rate
por: Grayling, Michael J., et al.
Publicado: (2018)

A web application for the design of multi-arm clinical trials
por: Grayling, Michael J., et al.
Publicado: (2020)

Phase II trial designs for complex interventions: a single-arm single-stage design for clustered continuous outcomes
por: Wilson, Duncan T, et al.
Publicado: (2015)

Designs for adding a treatment arm to an ongoing clinical trial
por: Bennett, Maxine, et al.
Publicado: (2020)

Stepped-wedge cluster randomised trials: where, when and why?
por: Grayling, Michael, et al.
Publicado: (2015)

A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis
por: Bratton, Daniel J, et al.
Publicado: (2013)

Curtailing infection
por: Williams, Ruth
Publicado: (2006)

Sample size re-estimation in crossover trials: application to the AIM HY-INFORM study
por: Wych, Julie, et al.
Publicado: (2019)

A multi-arm multi-stage design for binary outcomes and application to tuberculosis
por: Bratton, Daniel, et al.
Publicado: (2013)

Blinded and unblinded sample size reestimation in crossover trials balanced for period
por: Grayling, Michael J., et al.
Publicado: (2018)

Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes
por: Wason, James M. S., et al.
Publicado: (2012)

Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
por: Grayling, Michael J., et al.
Publicado: (2018)

Sources of bias for single-arm phase II cancer clinical trials
por: Jung, Sin-Ho
Publicado: (2022)

Modified Simon’s minimax and optimal two-stage designs for single-arm phase II cancer clinical trials
por: Kim, Jongphil, et al.
Publicado: (2019)

Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacy
por: Wilkins, Martin R., et al.
Publicado: (2021)

Mixed response and time-to-event endpoints for multistage single-arm phase II design
por: Lai, Xin, et al.
Publicado: (2015)

Response adaptive designs for Phase II trials with binary endpoint based on context-dependent information measures()
por: Kasianova, Ksenia, et al.
Publicado: (2021)

Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials
por: Mander, A.P., et al.
Publicado: (2010)

Optimal two-stage design of single arm Phase II clinical trials based on median event time test
por: Park, Yeonhee
Publicado: (2021)

Curtailing the collapse of the living world
por: Naeem, Shahid, et al.
Publicado: (2022)

Stochastic model search with binary outcomes for genome-wide association studies
por: Russu, Alberto, et al.
Publicado: (2012)

Memory Capacity of Networks with Stochastic Binary Synapses
por: Dubreuil, Alexis M., et al.
Publicado: (2014)

Memory capacity of networks with stochastic binary synapses
por: Dubreuil, Alexis, et al.
Publicado: (2013)

Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
por: Wason, James M S, et al.
Publicado: (2014)

Bayesian Sequential Monitoring of Single-Arm Trials: A Comparison of Futility Rules Based on Binary Data
por: Sambucini, Valeria
Publicado: (2021)

Immunotherapeutic approaches to curtail COVID-19
por: Owji, Hajar, et al.
Publicado: (2020)

Application of Bayesian predictive probability for interim futility analysis in single-arm phase II trial
por: Chen, Dung-Tsa, et al.
Publicado: (2019)

The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expected
por: Wason, James MS, et al.
Publicado: (2015)

A product of independent beta probabilities dose escalation design for dual-agent phase I trials
por: Mander, Adrian P, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r8em4fruc5idvqbj7cs9g6490h